Clinical Trial Update: The Combination of Immunotherapy and Neoadjuvant Chemoradiotherapy in MSI-H Locally Advanced Rectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial update exploring immunotherapy with neoadjuvant chemoradiotherapy in MSI-H locally advanced rectal cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rectal Cancer

Snippet

Sponsor: Fudan University | Conditions: Locally Advanced Rectal Cancer | Phase 2 | Status: UNKNOWN